Pre-exposure prophylaxis prescribing and retention in care among heterosexual women at a community-based comprehensive sexual health clinic

References

• Adimora, A. A., Schoenbach, V. J., Martinson, F. E., Coyne-Beasley, T., Doherty, I., Stancil, T. R., & Fullilove, R. E. (2006). Heterosexually transmitted HIV infection among African Americans in North Carolina. JAIDS Journal of Acquired Immune Deficiency Syndromes, 41(5), 616–623. doi:10.1097/01.qai.0000191382.62070.a5
   PubMed Web of Science ®Google Scholar
• Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., … Partners Pr, E. P. S. T. (2012). Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. New England Journal of Medicine, 367(5), 399–410. doi:10.1056/NEJMoa1108524
   PubMed Web of Science ®Google Scholar
• Blackstock, O. J., Frew, P., Bota, D., Vo-Green, L., Parker, K., Franks, J., … Mannheimer, S. B. (2015). Perceptions of community HIV/STI risk among U.S women living in areas with high poverty and HIV prevalence rates. Journal of Health Care for the Poor and Underserved, 26(3), 811–823. doi:10.1353/hpu.2015.0069
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2014). Preexposure prophylaxis for the prevention of HIV infection in the United States, 2014: A Clinical Practice Guideline. Retrieved from http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf
   Google Scholar
• Chan, P. A., Mena, L., Patel, R., Oldenburg, C. E., Beauchamps, L., Perez-Brumer, A. G., … Nunn, A. (2016). Retention in care outcomes for HIV pre-exposure prophylaxis implementation programmes among men who have sex with men in three US cities. Journal of the International AIDS Society, 19(1), 20903. doi:10.7448/IAS.19.1.20903
   PubMed Web of Science ®Google Scholar
• Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., … Team, H. S. (2016). Antiretroviral therapy for the prevention of HIV-1 transmission. New England Journal of Medicine, 375(9), 830–839. doi:10.1056/NEJMoa1600693
   PubMed Web of Science ®Google Scholar
• Cossarini, F. H. D., Ginsberg, M., Anastos, K., & Felsen, U. R. (2016). Characteristics of patients who become HIV infected despite accessing healthcare: Implications for HIV prevention strategies. Paper presented at the IDWeek 2016, New Orleans, LA.
   Google Scholar
• Doherty, I. A., Schoenbach, V. J., & Adimora, A. A. (2009). Sexual mixing patterns and heterosexual HIV transmission among African Americans in the Southeastern United States. JAIDS Journal of Acquired Immune Deficiency Syndromes, 52(1), 114–120. doi:10.1097/QAI.0b013e3181ab5e10
   PubMed Web of Science ®Google Scholar
• Garfinkel, D. B., Alexander, K. A., McDonald-Mosley, R., Willie, T. C., & Decker, M. R. (2016). Predictors of HIV-related risk perception and PrEP acceptability among young adult female family planning patients. AIDS Care, 1–8. doi:10.1080/09540121.2016.1234679
   PubMed Web of Science ®Google Scholar
• Gilead Sciences. Truvada for PrEP Medication Assistance Program. Retrieved January 25, 2017, from http://www.gilead.com/responsibility/us-patient-access/truvada20for20prep20medication20assistance%20program
   Google Scholar
• Hader, S. L., Smith, D. K., Moore, J. S., & Holmberg, S. D. (2001). HIV infection in women in the United States: Status at the Millennium. JAMA, 285(9), 1186–1192. doi: 10.1001/jama.285.9.1186
   PubMed Web of Science ®Google Scholar
• Marcus, J. L., Hurley, L. B., Hare, C. B., Nguyen, D. P., Phengrasamy, T., Silverberg, M. J., … Volk, J. E. (2016). Preexposure prophylaxis for HIV prevention in a large integrated healthcare system: adherence, renal safety, and discontinuation. JAIDS Journal of Acquired Immune Deficiency Syndromes, 73(5), 540–546. doi: 10.1097/QAI.0000000000001129
   PubMed Web of Science ®Google Scholar
• Mera R, McCallister, M. S., Palmer, B, Mayer, G., Magnuson, D., & Rawlings, M. K. (2016). FTC/TDF (Truvada) for HIV Pre-Exposure Prophylaxis (PrEP) Utilization in the United States: 2012−2015. Paper presented at the AIDS 2016, Durban, South Africa.
   Google Scholar
• New York City Department of Health and Mental Hygiene. (2014, April). HIV surveillance mid-year report, 2015. Retrieved from https://www1.nyc.gov/assets/doh/downloads/pdf/dires/first-half-2015-surviellance-statistics-tables.pdf
   Google Scholar
• New York State Department of Health. Pre-Exposure prophylaxis assistance program. Retrieved January 25, 2017, from https://www.health.ny.gov/diseases/aids/general/resources/adap/prep.htm
   Google Scholar
• Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., van Lunzen, J., … Group, P. S. (2016). Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy. JAMA, 316(2), 171–181. doi:10.1001/jama.2016.5148
   PubMed Web of Science ®Google Scholar
• Seidman, D. L., Weber, S., Timoney, M. T., Oza, K. K., Mullins, E., Cohan, D. L., & Wright, R. L. (2016). Use of HIV pre-exposure prophylaxis during the preconception, antepartum and postpartum periods at two United States medical centers. American Journal of Obstetrics and Gynecology. doi:10.1016/j.ajog.2016.06.020
   Web of Science ®Google Scholar
• Smith, D. K., Van Handel, M., Wolitski, R. J., Stryker, J. E., Hall, H. I., Prejean, J., …  Valleroy, L. A. (2015). Vital signs: Estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition–United States, 2015. MMWR. Morbidity and Mortality Weekly Report, 64(46), 1291–1295. doi:10.15585/mmwr.mm6446a4
   PubMed Web of Science ®Google Scholar
• Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., …  Group, T. D. F. S. (2012). Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. New England Journal of Medicine, 367(5), 423–434. doi:10.1056/NEJMoa1110711
   PubMed Web of Science ®Google Scholar